DE68907392D1 - Dysmnesie modifizierende arzneimittel. - Google Patents

Dysmnesie modifizierende arzneimittel.

Info

Publication number
DE68907392D1
DE68907392D1 DE8989120897T DE68907392T DE68907392D1 DE 68907392 D1 DE68907392 D1 DE 68907392D1 DE 8989120897 T DE8989120897 T DE 8989120897T DE 68907392 T DE68907392 T DE 68907392T DE 68907392 D1 DE68907392 D1 DE 68907392D1
Authority
DE
Germany
Prior art keywords
dysmnesia
modifying
medicinal products
medicinal
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE8989120897T
Other languages
English (en)
Other versions
DE68907392T2 (de
Inventor
Mitsuo Ohashi
Fukuraro Taga
Takashi Hirayama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE68907392D1 publication Critical patent/DE68907392D1/de
Publication of DE68907392T2 publication Critical patent/DE68907392T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE89120897T 1988-11-11 1989-11-10 Dysmnesie modifizierende Arzneimittel. Expired - Lifetime DE68907392T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP63285217A JPH085790B2 (ja) 1988-11-11 1988-11-11 記憶障害改善薬

Publications (2)

Publication Number Publication Date
DE68907392D1 true DE68907392D1 (de) 1993-08-05
DE68907392T2 DE68907392T2 (de) 1993-10-14

Family

ID=17688622

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89120897T Expired - Lifetime DE68907392T2 (de) 1988-11-11 1989-11-10 Dysmnesie modifizierende Arzneimittel.

Country Status (7)

Country Link
US (1) US4990516A (de)
EP (1) EP0368343B1 (de)
JP (1) JPH085790B2 (de)
KR (1) KR960006066B1 (de)
AU (1) AU614201B2 (de)
DE (1) DE68907392T2 (de)
ES (1) ES2057065T3 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280032A (en) * 1989-02-14 1994-01-18 Toyama Chemical Co., Ltd. 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same
JP2873898B2 (ja) * 1992-04-13 1999-03-24 富山化学工業株式会社 ベンゾ[b]チオフェン−5−イル誘導体もしくはその光学活性体またはそれらの塩並びにそれらの製造法
TWI312347B (en) 2001-02-08 2009-07-21 Eisai R&D Man Co Ltd Bicyclic nitrogen-containing condensed ring compounds
NZ529333A (en) * 2001-04-27 2005-01-28 Eisai Co Ltd Pyrazolo[1,5-a]pyridines and medicines containing the same
SI1555265T1 (sl) * 2002-10-22 2009-06-30 Eisai R&D Man Co Ltd 7-fenil pirazolopiridinske spojine
US7176216B2 (en) * 2002-10-22 2007-02-13 Eisai Co., Ltd. 7-phenylpyrazolopyridine compounds
JP4589122B2 (ja) 2002-12-03 2010-12-01 杏林製薬株式会社 ホスホジエステラーゼ10a阻害剤
CN102007133B (zh) 2008-04-15 2013-06-12 卫材R&D管理有限公司 3-苯基吡唑并[5,1-b]噻唑化合物
AR078521A1 (es) 2009-10-08 2011-11-16 Eisai R&D Man Co Ltd Compuesto pirazolotiazol
JPWO2011043387A1 (ja) * 2009-10-08 2013-03-04 エーザイ・アール・アンド・ディー・マネジメント株式会社 ピラゾロオキサゾール化合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5229318B2 (de) * 1972-03-30 1977-08-01
US4647566A (en) * 1984-07-09 1987-03-03 Ciba-Geigy Corporation Certain ring-fused pyrazolo[3,4-d]-pyridin-3-one derivatives in treating anxiety
JPS6263520A (ja) * 1985-09-14 1987-03-20 Kyorin Pharmaceut Co Ltd 抗リウマチ剤
JPH01153634A (ja) * 1987-12-10 1989-06-15 Kyorin Pharmaceut Co Ltd 吸入剤

Also Published As

Publication number Publication date
EP0368343A3 (en) 1990-12-27
EP0368343B1 (de) 1993-06-30
EP0368343A2 (de) 1990-05-16
US4990516A (en) 1991-02-05
DE68907392T2 (de) 1993-10-14
AU614201B2 (en) 1991-08-22
AU4446889A (en) 1990-05-17
KR900007415A (ko) 1990-06-01
KR960006066B1 (ko) 1996-05-08
JPH085790B2 (ja) 1996-01-24
JPH02131424A (ja) 1990-05-21
ES2057065T3 (es) 1994-10-16

Similar Documents

Publication Publication Date Title
DE69018647T2 (de) Arzneimittel.
DE69003568T2 (de) Arzneimittel mit verzögerter Freigabe.
DE3780223D1 (de) Arzneimittel mit gesteuerter freisetzung.
DE68914835D1 (de) Proteinerzeugnisse.
DE68911473T2 (de) Arzneimittelformulierungen.
NO892588L (no) Pulverpreparater.
DE69115229D1 (de) Arzneimittel.
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
NL194239B (nl) Dialkoxyfosfinolmethylbenzamideverbindingen en farmaceutische preparaten, die deze bevatten.
FI873630A (fi) Stabilt farmaceutiskt preparat.
FI893340A0 (fi) Foerfarande foer att erhaolla farmaceutiska sammansaettningar foer att hindra smittbara koenssjukdomar.
DE68908354D1 (de) Verpackung fuer arzneimittel.
FI893643A0 (fi) Farmaceutiska kompositioner.
DE68911417D1 (de) Cyclohexan-Derivate.
NO890453L (no) Artropodicide preparater.
DE68907392D1 (de) Dysmnesie modifizierende arzneimittel.
FI905236A0 (fi) Deoxiribonukleosider innehaollande farmaceutiska konsistenser foer laekning av saor.
DE3763519D1 (de) Heilnahrungsmittel.
FI901938A0 (fi) Silversulfadiazin innehaollande farmaceutiska produkter foer lokalt externt bruk.
NO891574L (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
DE3781045T2 (de) Antirheumatisches arzneimittel.
NO893311L (no) Mousse-produkt.
DE3889327D1 (de) Platinkomplexe enthaltende arzneimittel.
FI934317A0 (fi) Farmaceutiska sammansaettningar, vilka innehaoller ej-joniska ytaktiva aemnen
DE3887237D1 (de) Arzneimittel.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition